These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6197656)

  • 41. Mesocortical dopamine neurons: high basal firing frequency predicts tyrosine dependence of dopamine synthesis.
    Tam SY; Elsworth JD; Bradberry CW; Roth RH
    J Neural Transm Gen Sect; 1990; 81(2):97-110. PubMed ID: 2363911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area.
    Butts KA; Phillips AG
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1799-807. PubMed ID: 23590841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system.
    Mantz J; Thierry AM; Glowinski J
    Brain Res; 1989 Jan; 476(2):377-81. PubMed ID: 2702475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacology of mesocortical dopamine neurons.
    Bannon MJ; Roth RH
    Pharmacol Rev; 1983 Mar; 35(1):53-68. PubMed ID: 6138783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM; Nomikos GG; Schilström B; Svensson TH
    J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesolimbic dopamine mediates gastric mucosal protection by central neurotensin.
    Xing LP; Balaban C; Seaton J; Washington J; Kauffman G
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G34-8. PubMed ID: 1899007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM; Jones BJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation.
    Herve D; Studler JM; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1986 Sep; 383(1-2):47-53. PubMed ID: 3094831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbens.
    Elliott PJ; Nemeroff CB; Kilts CD
    Brain Res; 1986 Oct; 385(2):379-82. PubMed ID: 2430671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra.
    Pickel VM; Chan J; Sesack SR
    Brain Res; 1993 Feb; 602(2):275-89. PubMed ID: 8095430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of specific central dopamine pathways: locomotion and footshock.
    Speciale SG; Miller JD; McMillen BA; German DC
    Brain Res Bull; 1986 Jan; 16(1):33-8. PubMed ID: 3955388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones.
    Koga E; Momiyama T
    J Physiol; 2000 Feb; 523 Pt 1(Pt 1):163-73. PubMed ID: 10673553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro.
    Rice ME; Cragg SJ; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):853-62. PubMed ID: 9065854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H; Jonsson G
    Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N; Stewart J
    J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.
    Kalivas PW; Duffy P
    J Pharmacol Exp Ther; 1987 Apr; 241(1):204-12. PubMed ID: 3572784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area.
    Gessa GL; Muntoni F; Collu M; Vargiu L; Mereu G
    Brain Res; 1985 Nov; 348(1):201-3. PubMed ID: 2998561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of nucleus accumbens neurons to amygdala stimulation and its modification by dopamine.
    Yim CY; Mogenson GJ
    Brain Res; 1982 May; 239(2):401-15. PubMed ID: 6284305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphine-induced activation of A10 dopamine neurons in the rat.
    Gysling K; Wang RY
    Brain Res; 1983 Oct; 277(1):119-27. PubMed ID: 6315137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.